MEDICAL INQUIRIES MEDICAL INQUIRIES

THERAPEUTIC AREAS THERAPEUTIC AREAS

DISEASE AWARENESS DISEASE AWARENESS

DRUG PORTFOLIO DRUG PORTFOLIO

CONGRESSES AND PUBLICATIONS CONGRESSES AND PUBLICATIONS

Contact Us

Call 1-888-275-7376
(8-5:30 ET M-F)

Submit Med Info Request

Adverse Event:
1-800-283-8088, ext. 5563

eMedI Chat: Medical Information Database

Please click the eMedI Chat icon in the lower right corner of your screen to use our chatbot and search the Medical Information database

Temperature Stability Calculator

Have a question about a temperature excursion?

Therapeutic Areas

Discover our resource library on diseases, products, congresses, publications, and more, organized by therapeutic areas

Disease Awareness

Find information on disease areas of interest

Marketed Products

Find information on our marketed products

Pipeline Agents

Find information on our pipeline agents

Congress Presentations

Explore our library of congress presentations

Journal Publications

Discover our library of select journal publications

eMedI Chat

Interferon beta-1a Journal Publications

Search results containing information about pipeline products (current or former) or investigational uses of products do not imply Food and Drug Administration (FDA) approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. There is no guarantee that the pipeline products or investigational uses will receive FDA approval. EMD Serono, Inc. does not recommend or suggest use of its products in a manner inconsistent with FDA-approved labeling.

Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a US Claims Database.

Allignol | Front Neurol. 2021 Jul 22;12:676585.

The Association Between Exposure to Interferon-Beta During Pregnancy and Birth Measurements in Offspring of Women with Multiple Sclerosis.

Burkill | PLoS One. 2019;14(12):e0227120.

Randomised Double-Blind Placebo-Controlled Study of Interferon Beta-1a in Relapsing/Remitting Multiple Sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

Ebers | Lancet. 1998;352(9139):1498-1504.

Pregnancy Outcomes after Exposure to Interferon Beta: A Register-Based Cohort Study Among Women with MS in Finland and Sweden.

Hakkarainen | Ther Adv Neurol Disord. 2020;13:1756286420951072.

Transfer of Interferon β-1a into Human Breastmilk.

Hale | Breastfeed Med. 2012;7(2):123-125.

Factors Influencing Long-Term Outcomes in Relapsing-Remitting Multiple Sclerosis: PRISMS-15.

Kappos | J Neurol Neurosurg Psychiatry. 2015;86(11):1202-1207.

Magnetic Resonance Imaging Results of the PRISMS Trial: A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-Beta1a in Relapsing-Remitting Multiple Sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis.

Li | Ann Neurol. 1999 Aug;46(2):197-206.

Randomized, Comparative Study of Interferon Beta-1a Treatment Regimens in MS: The EVIDENCE Trial

Panitch | Neurology. 2002 Nov 26;59(10):1496-506.

Immune Response to Influenza Vaccine is Maintained in Patients with Multiple Sclerosis Receiving Interferon Beta-1a.

Schwid | Neurology. 2005;65(12):1964-1966.

This site is intended for US healthcare professionals only.

DISCLAIMER: This site contains medical information that is intended for healthcare providers of the United States only. The medical information contained on this site is not meant to substitute for the advice provided by a medical professional. Canadian residents should consult the EMD Serono Canada Inc. website at www.emdserono.ca for information on products and services approved in Canada. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.

EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada.

US-MULNP-00023 09/24

By clicking this link, you are leaving medical.emdserono.com. Please, note that this link will take you to a website on which different Privacy Policy and Conditions may apply. EMD Serono accepts no responsibility for websites not controlled directly by us. Please check Privacy Policy and Conditions of the linked website.

Welcome to EMD Serono Medical Information!

Help us direct you to the right information by selecting one of the following options: